title: Control of neuronal size homeostasis by trophic factor-mediated coupling of protein degradation to protein synthesis.
abstract: We demonstrate that NGF couples the rate of degradation of long-lived proteins in sympathetic neurons to the rate of protein synthesis. Inhibiting protein synthesis rate by a specific percentage caused an almost equivalent percentage reduction in the degradation rate of long-lived proteins, indicating nearly 1:1 coupling between the two processes. The rate of degradation of short-lived proteins was unaffected by suppressing protein synthesis. Included in the pool of proteins that had increased half-lives when protein synthesis was inhibited were actin and tubulin. Both of these proteins, which had half-lives of several days, exhibited no degradation over a 3-d period when protein synthesis was completely suppressed. The half-lives of seven other long-lived proteins were quantified and found to increase by 84-225% when protein synthesis was completely blocked. Degradation-synthesis coupling protected cells from protein loss during periods of decreased synthesis. The rate of protein synthesis greatly decreased and coupling between degradation and synthesis was lost after removal of NGF. Uncoupling resulted in net loss of cellular protein and somatic atrophy. We propose that coupling the rate of protein degradation to that of protein synthesis is a fundamental mechanism by which neurotrophic factors maintain homeostatic control of neuronal size and perhaps growth.
authors.affiliation: Department of Neurological Surgery, 4640 MSC, University of Wisconsin School of Medicine, Madison, Wisconsin 53706, USA. jlfrankl@facstaff.wisc.edu
authors.forename: J L
authors.initials: JL
authors.lastname: Franklin
authors.forename: E M
authors.initials: EM
authors.lastname: Johnson
mesh_terms: D000199:Actins / Q000378:metabolism; D000818:Animals; D000841:Anisomycin / Q000494:pharmacology; D017209:Apoptosis / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D048429:Cell Size / Q000502:physiology*; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004622:Embryo, Mammalian / Q000502:physiology; D005724:Ganglia / Q000196:embryology; D006706:Homeostasis / Q000502:physiology*; D007700:Kinetics; D008858:Microscopy, Phase-Contrast; D009414:Nerve Growth Factors / Q000502:physiology*; D009419:Nerve Tissue Proteins / Q000378:metabolism* / Q000502:physiology*; D009474:Neurons / Q000502:physiology; D014176:Protein Biosynthesis / Q000187:drug effects; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014158:Transcription, Genetic / Q000235:genetics; D014404:Tubulin / Q000378:metabolism
chemical_list: D000199:Actins; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D011500:Protein Synthesis Inhibitors; D014404:Tubulin; D003609:Dactinomycin; D000841:Anisomycin; D003513:Cycloheximide